Morphine (Mst Continus)
Morphine
Mundipharma (Pty) Ltd
Registration
- Applicant
- Mundipharma (Pty) Ltd
- Registrations
- 4
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Mst continus 10 MG tablet EACH TABLET CONTAINS MORPHINE SULPHATE 10 mg | 10 mgTablet | R0294R/2.9/294 | Registered | Not determined | None |
| Mst continus 30 MG tablet EACH TABLET CONTAINS MORPHINE SULPHATE 30 mg | 30 mgTablet | R0295R/2.9/295 | Registered | Not determined | None |
| Mst continus 60 MG tablet EACH TABLET CONTAINS MORPHINE SULPHATE 60 mg | 60 mgTablet | S0278S/2.9/278 | Registered | Not determined | None |
| Mst continus 100 MG tablet EACH TABLET CONTAINS MORPHINE SULPHATE 100 mg | 100 mgTablet | S0279S/2.9/279 | Registered | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S6: Morphine
- except preparations and mixtures of morphine containing 0,2 percent or less of morphine, calculated as anhydrous morphine. (S2)
Consolidated Schedules 06 July 2026, lines 10318 to 10319
S2: Morphine
- mixtures containing 0,2 percent or less of morphine, calculated as anhydrous morphine.
Consolidated Schedules 06 July 2026, line 2355
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
(4R,4AR,7S,7aR,12bS)-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol
Drag to rotate. Structure from PubChem CID 5288826.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.